InsidersTradesSigma
Browse the full record of transactions filed by Lettmann Jason, Director. Director active across 1 companies, notably ALX Oncology Holdings INC. Aggregated, 4 disclosures have been recorded. Total volume traded: €2.6m. The latest transaction was disclosed on 13 December 2021 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Jason Lettmann is a Board Member at ALX Oncology Holdings Inc. He plays a key role in the company's governance, contributing to strategy and decision-making. His experience is valuable for the development of ALX Oncology.